Thomas Civik's Net Worth
$5.83 Million
Who is Thomas Civik?
Thomas Civik has an estimated net worth of $5.83 Million. This is based on reported shares across multiple companies, which include Repare Therapeutics Inc., Foundation Medicine, Inc., Pyxis Oncology, Inc., and FIVE PRIME THERAPEUTICS, INC..
SEC CIK
Thomas Civik's CIK is 0001723092
Past Insider Trading and Trends
2021 was Thomas Civik's most active year for acquiring shares with 4 total transactions. Thomas Civik's most active month to acquire stocks was the month of February. 2021 was Thomas Civik's most active year for disposing of shares, totalling 3 transactions. Thomas Civik's most active month to dispose stocks was the month of March. 2018 saw Thomas Civik paying a total of $2,279,312.20 for 33,421 shares, this is the most they've acquired in one year. In 2018 Thomas Civik cashed out on 33,421 shares for a total of $4,578,677.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Repare Therapeutics Inc. (RPTX) Snapshot price: $7.83
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
∞
| 7.5K |
$28.08 | $210,600.00 | 7.5K |
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Foundation Medicine, Inc. No price found
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -33.42K |
$137.00 | -$4,578,677.00 |
0
|
Jul 31
| |||
Form 4
|
∞
| 33.42K |
$68.20 | $2,279,312.20 | 33.42K |
Jan 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pyxis Oncology, Inc. (PYXS) Snapshot price: $3.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 26
| |||
Form 4
| +208.52% | 139.35K |
—
|
—
| 206.19K |
Mar 24
| |||
Form 4
|
∞
| 66.83K |
—
|
—
| 66.83K |
Mar 31
| |||
Form 4
|
∞
| 15.7K |
$12.74 | $200,018.00 | 15.7K |
Nov 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FIVE PRIME THERAPEUTICS, INC. No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -68.97K |
$38.00 | -$2,620,898.00 |
0
|
Apr 16
| |||
Form 4
| -13.85% | -11.09K |
$37.94 | -$420,678.72 | 68.97K |
Apr 9
| |||
Form 4
|
∞
| 75K |
—
|
—
| 75K |
Apr 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||